NCT05098457View on ClinicalTrials.gov

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 22, 2022

Primary Completion Date

February 19, 2023

Study Completion Date

November 18, 2023

Conditions
Cheek WrinklesMidface Contour Deficiencies
Interventions
DEVICE

GP0112

Injectable gel

DEVICE

Restylane Lyft Lidocaine

Injectable gel

Trial Locations (8)

20146

Galderma Research Site, Hamburg

22609

Galderma Research Site, Hamburg

40212

Galderma Research Site, Düsseldorf

40545

Galderma Research Site, Düsseldorf

42287

Galderma Research Site, Wuppertal

50996

Galderma Research Site, Cologne

64283

Galderma Research Site, Darmstadt

80469

Galderma Research Site, Munich

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT05098457 - Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction | Biotech Hunter | Biotech Hunter